Literature DB >> 14556059

Analysis of prognostic factors in 95 patients with Acinetobacter baumannii bacteremia.

C-H Chen1, L-C Lin, Y-J Chang, C-C Huang, C-E Liu, T-G Young.   

Abstract

BACKGROUND: Because Acinetobacter baumannii bacteremia is a global problem, we were motivated to characterize this disease in Taiwan. PATIENTS AND METHODS: We analyzed findings in 95 patients with documented A. baumannii bacteremia between January 1, 1998 and December 31, 2000 (47 men, 48 women; mean age 58.8 years).
RESULTS: The mean length of stay in the hospital was 44.0 days. Clinically, 76 patients had fever and 35 patients developed shock. Fifty patients had respiratory tract infections; 24, urinary tract infections; 11, intra-abdominal infections; three, CNS infections; and two, catheter-related infections. Five patients had primary bacteremia. Empirical antibiotic therapy was initiated at the onset of the clinical signs of infection. Antimicrobial susceptibility test results were variable. 47 patients died and 48 survived; the mortality rate for A. baumannii bacteremia was 45.3% (43/95).
CONCLUSION: Physicians should pay attention to this infection because the early identification of high-risk patients could facilitate prophylaxis and potentially reduce associated problems.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14556059     DOI: 10.1007/s15010-003-3223-1

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  10 in total

1.  Clinical characteristics and outcomes of bacteremia due to different genomic species of Acinetobacter baumannii complex in patients with solid tumors.

Authors:  M-C Chiang; S-C Kuo; S-J Chen; S-P Yang; Y-T Lee; T-L Chen; C-P Fung
Journal:  Infection       Date:  2011-09-02       Impact factor: 3.553

2.  Acinetobacter baumannii bacteraemia in patients with haematological malignancy: a multicentre retrospective study from the Infection Working Party of Jiangsu Society of Hematology.

Authors:  X Wang; L Zhang; A Sun; X Yang; W Sang; Y Jiang; J Cheng; J Wang; M Zhou; B Chen; J Ouyang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-01-18       Impact factor: 3.267

3.  High and increasing Oxa-51 DNA load predict mortality in Acinetobacter baumannii bacteremia: implication for pathogenesis and evaluation of therapy.

Authors:  Yu-Chung Chuang; Shan-Chwen Chang; Wei-Kung Wang
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

4.  Quantitative proteomic analysis of host--pathogen interactions: a study of Acinetobacter baumannii responses to host airways.

Authors:  Jose Antonio Méndez; Jesús Mateos; Alejandro Beceiro; María Lopez; María Tomás; Margarita Poza; Germán Bou
Journal:  BMC Genomics       Date:  2015-05-30       Impact factor: 3.969

5.  Should we treat patients with only one set of positive blood cultures for extensively drug-resistant Acinetobacter baumannii the same as multiple sets?

Authors:  Aristine Cheng; Yu-Chung Chuang; Hsin-Yun Sun; Chia-Jui Yang; Hou-Tai Chang; Jia-Ling Yang; Wang-Huei Sheng; Yee-Chun Chen; Shan-Chwen Chang
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

6.  A Case of Polymicrobial Bacteremia in a Patient Undergoing Chemotherapy.

Authors:  Kyoko Arahata; Ryo Yamaguchi; Takeshi Terashima
Journal:  Case Rep Infect Dis       Date:  2018-01-15

7.  Long-term effectiveness of infection and antibiotic control programs on the transmission of carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex in central Taiwan.

Authors:  C-H Chen; L-C Lin; Y-J Chang; C-E Liu; M-S Soon
Journal:  Med Mal Infect       Date:  2015-05-28       Impact factor: 2.152

8.  ICU-associated Acinetobacter baumannii colonisation/infection in a high HIV-prevalence resource-poor setting.

Authors:  Ntobeko B A Ntusi; Motasim Badri; Hoosain Khalfey; Andrew Whitelaw; Stephen Oliver; Jenna Piercy; Richard Raine; Ivan Joubert; Keertan Dheda
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

Review 9.  Infection Control Programs and Antibiotic Control Programs to Limit Transmission of Multi-Drug Resistant Acinetobacter baumannii Infections: Evolution of Old Problems and New Challenges for Institutes.

Authors:  Chang-Hua Chen; Li-Chen Lin; Yu-Jun Chang; Yu-Min Chen; Chin-Yen Chang; Chieh-Chen Huang
Journal:  Int J Environ Res Public Health       Date:  2015-07-30       Impact factor: 3.390

10.  Acinetobacter baumannii infection in a medical intensive care unit: The impact of strict infection control.

Authors:  A M Aboshakwa; U Lalla; E M Irusen; C F N Koegelenberg
Journal:  Afr J Thorac Crit Care Med       Date:  2019-04-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.